Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Gilead Sciences Inc buy Truist Financial Co.

Start price
€69.22
06.09.23 / 50%
Target price
€84.81
06.09.24
Performance (%)
-10.04%
Price
€60.18
03.05.24
Summary
This prediction is currently active. The price of Gilead Sciences Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.04%. A total of €2.09 was paid as dividends for this prediction. This prediction currently runs until 06.09.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Gilead Sciences Inc -1.570% -1.570%
iShares Core DAX® -0.922% -1.078%
iShares Nasdaq 100 0.371% -0.556%
iShares Nikkei 225® 2.224% -2.825%
iShares S&P 500 -0.026% -0.788%

Comments by Truist_Financial_Co_ for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Buy
Perf. (%) -10.04%
Target price 84.812
Change
Ends at 06.09.24

Gilead Sciences, Inc. (NASDAQ: GILD) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $91.00 price target on the stock.
Ratings data for GILD provided by MarketBeat